How to get the most from methotrexate (MTX) treatment for your rheumatoid arthritis patient?—MTX in the treat-to-target strategy
Methotrexate (MTX) is a remarkable drug with a key role in the management of rheumatoid arthritis (RA) at every stage of its evolution. Its attributes include good overall efficacy for signs and symptoms, inhibition of structural damage and preservation of function with acceptable and manageable saf...
Egile Nagusiak: | Taylor, P, Criado, AB, Mongey, A-B, Avouac, J, Marotte, H, Mueller, RB |
---|---|
Formatua: | Journal article |
Argitaratua: |
MDPI
2019
|
Antzeko izenburuak
-
Methotrexate (MTX) Plus Hydroxychloroquine versus MTX Plus Leflunomide in Patients with MTX-Resistant Active Rheumatoid Arthritis: A 2-Year Cohort Study in Real World
nork: Zhang L, et al.
Argitaratua: (2020-12-01) -
Treatment of methotrexate (MTX) intolerance: behavioural therapy, versus switch to parenteral MTX versus oral MTX
nork: Wulffraat NM, et al.
Argitaratua: (2011-09-01) -
International Survey to Evaluate Current Options for Subcutaneous Injection of Methotrexate (MTX) and a New Button-Free MTX Autoinjector
nork: Müller-Ladner U, et al.
Argitaratua: (2024-03-01) -
Methotrexate (MTX) failed to control giant cell arteritis (GCA)
nork: Hoffman, G, et al.
Argitaratua: (2001) -
Predictors and clinical features of methotrexate (MTX) therapy for ectopic pregnancy
nork: Jing Zhang, et al.
Argitaratua: (2020-10-01)